Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Dragonfly Therapeutics
Biotech
Dragonfly asset flies home as BMS deal crumbles
Bristol Myers Squibb has dropped an oncology candidate it licensed in 2020 back into Dragonfly's pond.
Gabrielle Masson
Feb 6, 2023 11:20am
New federal biotech commission taps 12 members—Chutes & Ladders
Feb 3, 2023 10:20am
Novel cancer vaccines look beyond T cells to better fight tumors
May 27, 2022 2:00pm
Gilead joins Big Pharma peers at Dragonfly's pond in $300M deal
May 2, 2022 9:50am
Merck taps 2nd asset in $700M Dragonfly pact, bio abuzz with BMS
Nov 24, 2021 7:05am
Merck opts in for Dragonfly's TriNKET cancer program
Dec 2, 2020 8:22am
